STILLEY WILLIAM B. III (Chief Executive Officer) received a stock award from ADIAL PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/25/2023ACC: 0001213900-23-043129
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
+290.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
290.80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+240.80K
Price / share
—
Trade value
—
% of position
23.6%
5/23/2023
1.02M→1.26M
Total
Net shares
+240.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2023 | A · Award | +240.80K | — | — | 23.6% | 1.02M | 1.26M |
| Total | +240.80K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
0.3025
Held after
50K
Exercisable
—
5/23/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 5/23/2023 | A · Award | +50K | 0.3025 | — | 50K |